Asia Pacific Blood Glucose Test Strip Market Research Report - Forecast till 2027

Asia Pacific Blood Glucose Test Strip Market Information: By Types (Glucose Oxidase, Glucose Dehydrogenase, other), By Technology (Wicking Technology and Channel Technology), and By End User (Hospital, Clinic, Household) -Forecast till 2027

ID: MRFR/MED/0182-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario
Diabetes a metabolic condition that occurs due to insufficient production of insulin. Blood glucose monitoring is a routine procedure for monitoring the glucose level. Blood glucose strip market is continuously growing in the Asia pacific region. These devices monitor the glucose level in the blood. Different types of strips are available in the market having impregnate of glucose oxidase, glucose dehydrogenase and other type of enzymes. When blood comes in the contact with this enzymes, they react with the glucose in the blood and indicates the blood glucose level. Advances and development in the technology has introduced the number of different devices in the market. The major driving factor for the blood glucose test strip is continuously increasing diabetes population. Diabetic population is constantly increasing and glucose level monitoring is an important part of diagnosis and treatment of diabetes. Patient with diseases, for instance, diabetes can now live longer and healthier life due to continuously monitoring of disease. Additionally, increasing awareness about preventive care of various diseases, rising obese population, and changing lifestyle boosting the growth of the market. However, lack of accuracy and relatively high chances of false positive results may slow the growth of the market.

Asia Pacific is the growing market and is expected to grow at a CAGR of 6% during the forecasted period of 2017- 2023.
 Figure- Asia Pacific blood glucose test strip market, by types
Asia Pacific Blood Glucose Test Strip Market

Source- World Health Organization (WHO, white paper, company presentation, annual report

Key Players
Some of the major key players in the market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany).

Asia Pacific blood glucose test strip market is segmented on basis of types, technology and end users.

On the basis of types, the market is segmented into glucose oxidase, glucose dehydrogenase, and other.

On the basis of technology, the market is segmented into wicking technology and channel technology.

On the basis of end user, the market is categorised in hospital, clinic, homecare and others


 Regional Analysis
Asia Pacific blood glucose test strip market is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia Pacific. It is the fastest growing region in the global blood glucose strip market. The diabetic population in Asia Pacific is increasing continuously, which is the major driver the market. According to the World Health Organization (WHO), total diabetic population of India and China in 2012 was 61 million and 90 million respectively. Moreover, increasing awareness among the people, increasing healthcare expenditure and rising obese population have fuelled the growth of the market. China and India are the two major contributor to the Asia Pacific glucose test strip market owing to the presence of huge diabetic population.

Market Assessment
Asia Pacific Blood Glucose Test Strip Market-

Source: World Health Organization (WHO, white paper, company presentation, annual report

Intended Audience

  • Medical Devices manufacturers

  • Government and private research companies

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities




1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porter’s Five Forces

5.3 Demand & Supply: Gap analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 UP-Coming trends in Asia Pacific Blood Glucose Test Strip Market

5.7.1 Market trends

5.7.2 Technological trends

6. Asia Pacific Blood Glucose Test Strip market by type

6.1 Glucose Oxidase

6.2 Glucose Dehydrogenase

6.3 Other

7. Asia Pacific Blood Glucose Test Strip Market by technology

7.1 Wicking technology

7.2 Channel technology

8. Asia Pacific Blood Glucose Test Strip Market by End User

8.1 Hospital

8.2 Clinic

8.3 Household

9. Asia Pacific Blood Glucose Test Strip Market by Region

9.1 Introduction

9.1 Japan

9.2 China

9.3 India

9.4 Australia

9.5 Republic of Korea

9.5 Rest of Asia Pacific

10 Competitive Landscape

11 Company Profile

11.1 F. Hoffmann-La Roche Ltd

11.1.1 Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 Abbott

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Updates

11.2.4 Key Developments

11.3 LifeScan, Inc.

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Updates

11.3.4 Key Development

11.4 i-SENS. Inc.

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Updates

11.4.4 Key Development

11.5 AgaMatrix

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Updates

11.5.4 Key Developments

11.6 TaiDoc Technology Corporation

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Updates

11.6.4 Key Developments

11.7 BioSensors, Inc.

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Updates

11.7.4 Key Developments

11.8 Universal Biosensors

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Updates

11.8.4 Key Developments

11.9 Beijing Yicheng Electronic Co., Ltd

11.9.1 Overview

11.9.2 Product/Business Segment Overview

11.9.3 Financial Updates

11.9.4 Key Developments

11.10 Others

12 Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Medical Devices Industry

13 Appendix